Description
Ironclad Bundle
The Ironclad Bundle is a four-vial collection containing:
- CJC-1295 + Ipamorelin
- TB-500
- BPC-157
- Ipamorelin
The combination includes a CJC-1295/Ipamorelin product and an additional Ipamorelin vial. Research into the individual ingredients covers growth-hormone signaling and preclinical tissue-response pathways. The bundle itself is not an established clinical protocol.
How It Works
CJC-1295 is investigated for effects on growth-hormone-releasing hormone signaling, while Ipamorelin is studied as a growth-hormone secretagogue. TB-500-related research concerns thymosin-beta-4-derived sequences, and BPC-157 has mainly been examined in preclinical models.
POTENTIAL RESEARCH INTEREST
- Growth-hormone signaling: CJC-1295 and Ipamorelin are studied in secretagogue-related research.
- Peptide response: The combination offers a setting for investigating more than one signaling agent.
- Tissue-response models: BPC-157 has been investigated in preclinical research.
- Cell-movement pathways: TB-500-related studies explore processes associated with thymosin beta-4.
Side Effects and Safety
The safety of combining these materials has not been established. Results from CJC-1295 formulations containing DAC should not automatically be applied to No-DAC versions.
Dosage
No validated human-use dosage exists for this bundle. Its component amounts describe product composition, not a recommended dosing schedule.
Handling & Safety
Verify the formulation of CJC-1295 and the identity of every vial. Follow suitable laboratory controls.
Where to Find Ironclad Bundle
IML provides research-focused information and links to independent suppliers, who handle transactions and fulfillment.
Affiliate Disclosure: IronMountainLabz does not sell or ship this bundle. Links on this page may direct readers to independent suppliers through affiliate links.
